Annual General Meeting 2023

The Annual General Meeting took place on 21 March 2023

All documents related to the meeting can be found here


To watch a replay of the webcast, please follow the link below. 

Watch the webcast

This is Lundbeck

We are one of the only pharmaceutical companies in the world focusing exclusively on brain diseases, and we’re set apart by our specialization. 

About Us

With more than 70 years of neuroscience expertise, Lundbeck has developed and commercialized some of the world's most widely prescribed therapies for brain diseases.

Our Science

LATEST NEWS

See All News

Come join us in making a difference to patients worldwide.

Job Opportunities

Explore the latest financial developments at Lundbeck.

Investors

a better life for people with brain diseases

At Lundbeck, we see patients as people and are committed to support the person behind the disease. 

Patients

Partnering

The complexity of brain diseases requires a concerted effort. We are committed to develop new and better treatment options from innovations born in house or externally.

Read More
Mara Formentini on working at Lundbeck

Bringing Your Whole Self to Work and its Rewards

Read More
See All Stories

Lundbeck at a glance

100

countries where our products are sold

5,400

employees supporting our purpose

1915

year Lundbeck was founded